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UK. Howe\'er, in the Black group anencephaly is 50% more
common than spina bifida. Ir is possible ro speculate that this
might be a result of local facrors, as it is contrary ro findings
reported from Natal.3
Recent data from LiverpooJ1 indicate an appreciable decline in
the incidence of NTDs over the last few years for which no single
reason can be identified. Our figures for 1979 and 1980 were
slightlY lower than those for the preceding years, although nor ro
a statistically significant extent; this may be due to the cyclical
peaks and troughs previously recorded in association with
NTDs.4 .s
\'('e intend to continue monitoring the incidence of NTDs in
the Cape Town area so that a sound statistical basis can be
. established for decisions regarding the prevention and long-term
management thereof.
\'lIe are grateful ro Sisters Dunstan and Merckel for their
enthusiastic help in tracing cases, ro Dr H. A. van Coeverden de
Groot for supplying details of rotal numbers of births, and ro Gillian
Shapley for typing the manuscript.
This investigation was supported by grants from the South
African Medical Research Council and the University ofCape Town
Staff Research Fund.
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Jaundice following bone marrow
transplantation
The problem of diagnosis
P. PILLANS, N. NOVITSKY, P. JACOBS
Summary
Jaundice presented a major diagnostic and
therapeutic problem in 6 out of 20 patients
undergoing allogeneic bone marrow
transplantation for severe acute aplastic anaem ia or
leukaemia in relapse. In the first 2 cases histological
features of graft-versus-host disease were
demonstrable in the skin but absent in the liver. In
the 3rd case B-virus hepatitis was the most likely
diagnosis, in the 4th cumulative cytotoxic
chemotherapy was incriminated, and in the last 2
cases the jaundice was obstructive. These 6 cases
illustrate the varied causation of jaundice in patients
undergoing bone marrow transplantation, and
emphasize that correct diagnosis is essential for
rational management.
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Bone marrow transplantation is established as the preferred form
of treatment for patients with severe acute aplastic anaemia and
immunodeficiency disease whenever an HLA-identical and
MLC-non-reactive donor is available. The role of this procedure
in patients with acute leukaemia is less clearly defined, but it
offers a definite therapeutic option even in patients who have
relapsed and who have therefore usually received large doses of
cytotoxic d rugs, many of which are hepatotoxic. Des pite careful
matching between donor and recipient graft rejection may occur
and patients therefore receive immunosuppressive therapy,
which is associated with an increased risk of opportunistic
infection, septicaemia and subsequent liver dysfunction.
Jaundice may also be associated with the administration of
antibiotics or follow the infusion of blood or blood products
transmitting viral hepatitis.
Graft-versus-host disease (GVHD) is a unique process which
occurs after a successful transplant in patients in whom donor
lymphocytes mount an inflammatory reaction, predominantly
against the skin, gastro-intestinal tract and liver of the recipient.
Apart from the morbidity and mortality associated with this
syndrome, it is a classic cause of hepatitis.
The management of jaundice depends upon its cause, and
some of the diagnostic difficulties in the patient who has recently
received a transplant are illustrated by our experience with 6
patients.
Transplantation procedure
The recipient is conditioned with high-dose cyclophosphamide
for aplastic anaemia and with additional radiotherapy for
relapsed leukaemia, using the protocol described by Thomas and
Storb of Seattle. 1 The patient is nursed in reverse isolation and
recei\'es such allogeneic white cell and platelet suppOrt, collected
from the donor by continuous-flow centrifugation,1 as is
appropriate.
Marrow-rich blood is collected under general anaesthesia
from the compatible donor, using multiple small-volume
aspirations, infusing between 1,5 and 4,0 x 108 nucleated cells per
kilogram, and adequacy of the graft is monitored by in vif/'o bone
marrow culture.' Donors usually leave hospital on the same day.
Both donor and recipient are screened for hepatitis antigen
and cytomegalo\'irus infection, and have a biochemical profile
established on their first clinic visit. Methotrexate is
administered after transplantation to try and reduce the
incidence of G VHD. Hyperalimentation is given using a central
\'enous cannula,~ and supplementary trace elements, electrolytes
and \'itamins are provided until adequate absorption is re-
established after transplantation.
Case reports
Case 1
A 24-year-old White man presented with a 3-month history of
malaise, tiredness, and increasing shortness of breath on
exertion. He had previously been well and had no past history of
jaundice or any li\'er disease. On examination he was found to
ha\'e a temperature of 37,8°C and multiple pustules over his
back. There \\'as no jaundice, and apart from pallor the
remainder of the examination was negative.
Im'estigations revealed a haemoglobin concentration of 6,2
gldl, a reticulocyte index of 0,9%, and a white cell count of
5,5 x 10911 with 61 % neutrophils, 3% eosinophils and 36%
lymphocytes. The platelet count was 34 x 10911. Bone marrow
aspiration and trephine biopsy findings fulfilled the
morphological requirements for the diagno is ofaplasia. 5 Plasma
protein, bilirubin and alkaline phosphatase values and liver
enzyme !e\'els were normal.
On 14 February 1978 the patient received a transplant of bone
marrow from his HLA-identical, MLC-non-reactive brother.
The initial po toperative course was uneventful except for
streptococcal pharyngotonsillitis which responded promptly ro
antibiotics.
He made satisfactory progress with evidence of successful
marrow engraftment, but 6 weeks after discharge the serum
glutamic oxalo-acetic transaminase (SGOT) value was 231 lUll
(normal 10 - 50 lUll), and 3 weeks later was higher than 300
lUll. The aspartate transaminase level was 205 lUll (normal 0-
12 lUll), and the toral bilirubin level rose to 146 !1mol/l (normal
9 - 17 !1mol/I), ofwhich 125 !1mol/l was conjugated. The alkaline
phosphatase level was 218 I 11 (normal 30 - 85 lUll). The last
dose of methotrexate had been given 10 days previously.
The patient complained of nausea and watery diarrhoea. On
examination he was icteric bur apyrexial. There were no stigmata
of chronic liver disease and no hepatomegaly or splenomegaly.
The haemoglobin concentration was 13,6 gldl, the white cell
count 4,7 x 109/1 with 33% neutrophils, 14% Iymphocytes, 34%
eosinophils, 18% monocytes and 1% basophils, and the platelet
count 245 x 10911. Serum urea, creatinine and electrolyte levels
were normal. The total protein level was 72 gll, the albumin level
43 gll, and the prothrombin index 93%. Radio-immunoas ay for
hepatitis B surface antigen was negative, as was the Paul-Bunnell
test. There was no rise in cytomegalovirus titre.
A liver biopsy perf9rmed at this time revealed that the portal
tracts contained inflammatory cell infiltrates, with eosinophils
being fairly conspicuous. Several Councilman bodies were-
present and there were a few aggregates of Kupffer cells,
indicating death of several hepatocytes rogether. Ballooning
degeneration was not a feature. There was some evidence of
regeneration. The architecture was preserved, and the limiting
plates were intact. No cholestasis was evident. These features
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were thought to indicate drug-induced hepatitis, but GVHD
and viral hepatitis could not be excluded.
The bilirubin and liver enzyme values slowly returned to
normal, and during the 11 months following transplantation the
alkaline phosphatase level rose to 940 lUll.
The patient is now well, with a dry, rough, scaly rash on his
neck and back. Biopsy revealed chronic GVHD (grade I) with
hyperkeratosis, follicular plugging, atrophy of the epithelial
layer, and vacuolar changes in the basal layer.
Comments. Despite full investigation, including liver
biopsy, the pathogenesis of the hepatic disease remained
uncertain. Drug-induced hepatitis, A-virus or non-A, non-B
hepatitis and GVHD could all have accounted for the clinical
and histological features. The patient had histological evidence
of chronic GVHD in the skin, and the elevated alkaline
phosphatase level is compatible with this diagnosis. Liver biopsy
has not yet been repeated.
Case 2
A 16-year-old White youth was referred with a diagnosis of
Fanconi's anaemia. In 1971 he had been treated with
oxymetholone 50 mgld, which was later cjecreased to 25 mg/d
and subsequently increased to 100 mgld towards the end of
1974. Prednisone 30 mg on alternate days was also added at this
stage. In August 1978 he had been admitted with fever and
jaundice, thought to be due to non-A, non-B hepatitis.
Oxymetholone was also considered to be a possible cause of the
hepatitis and was discontinued. Bone marrow transplantation
was performed on 9 December 1978 with subsequent successful
engraftment.
He was pyrexial for at least a week before the transplant, with
spiking temperatures up to 39,5°C." Blood, urine, and stool
cultures were repeatedly negative, although a throat swab
revealed B-haemolytic streptococci. Intravenous antibiotics used
included co-trimoxazole, penicillin, metronidazole and
tobramycin. Fever persisted, and on the 9th day after
trarisplantation an extensive erythematous rash appeared which
rapidly became bullous, resulting in desquamation, especially of
the face, axillae, groin and buttocks. The rash was typical ofacute
GVHD and skin biopsy revealed the major changes to be in the
epidermis, where there was spongiosis and early bullous
formation with dyskeratotic cells (Civatte bodies). Although
there were no Iymphocytes in the dermis, the features were
considered diagnostic of GVHD.
At the same time gastro-intestinal symptoms developed,
including anorexia, nausea, and profuse diarrhoea of up to 6
litres a day. Hepatic involvement was evidenced by rapidly
progressive jaundice and tender hepatomegaly.
Investigations revealed a haemoglobin concentration of 8,7
gldl, a white cell count of 0,7 x 109 /1, with only a few
lymphocytes and monocytes present on the peripheral smear,
and a platelet count of 14 x 109 /1. Serum urea, creatinine and
electrolyte levels were normal. Other values were as follows:
serum rotal protein 52 gll, albumin 31 gll, total bilirubin 57
!1mol/l, of which 47 !1mol/l was conjugated, alkaline
phosphatase 51 lUll and SGOT 89 lUll. The toral bilirubin
rose progressively to 508 !1mol/l, of which 325 !1molll was
conjugated. The alkaline phosphatase level rose to 223 lUll and
the SGOT level to 163 I 11, while the serum protein level fell to
34 gll and the albumin level to 22 gll. Cultures of the stool, urine
and a throat swab were all negative.
Treatment of the G VHD included a single dose of vincristine
1,5 mg intravenously and intravenous methylprednisolone 100
mg/d. The patient received white cell support daily and blood
transfusions for anaemia. Because of persisting pyrexia large
doses of intravenous penicillin, carbenicillin, cloxacillin,
tobramycin, metronidazole, amikacin, and amphotericin B were
administered. His general state deteriorated. The skin rash was
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severe and extensive and resembled a severe scald. He died on 8
January 1979.
Autopsy showed the skin to contain all the typical features of
GVHD reaction with hyperkeratosis, parakeratosis, epidermal
atrophy, and associated dyskeratotic cells throughout the
epidermal layer. There was some increased collagen in the
papillary dermis but no lymphoid infiltrate. On examination of
the gastro-intestinal tract it was found that the small intestine
was atrophic, this affecting mainly the lamina propria and
superficial submucosa. There was a slight increase in collagen
and the cells present were mainly fibroblasts, with occasional
large mononuclear cells, lymphocytes and scanty plasma cells.
There were focal areas of epithelial regeneration as well as
widespread intramucosal haemorrhage. The submucosa showed
some degree of oedema, with scanered mononuclear and plasma
cells. The muscular layers were not affected. The colon showed
similar features affecting the superficial layers, but in areas there
was ulceration with pseudohyphae of Candida present in the
exudate and also extending into the tissue. In the liver the most
striking feature was predominantly centrilobular intrahepatic
cholestasis. The architecture was preserved, and the portal
tracts were of normal size and contained the normal population
of cells. There was no bile duct reduplication. In the areas
showing cholestasis there were bile plugs and occasional small
bile lakes with occasional cells showing eosinophilic
degeneration and necrosis. Bile was prominent in both
parenchymal and Kupffer cells, although some of the Kupffer
cells also appeared to contain haemosiderin. Some of the
hepatocytes had a slightly glassy appearance.
Comment. The clinical picture was typical of GVHD and
illustrates the difficulty of management, even when a firm
diagnosis has been established. There was histological evidence
of GVDH in the skin and gastro-intestinal tract, but the liver
appearance was not typical.
Case 3
A 6-year-old Coloured girl was referred with the diagnosis of
severe acute aplastic anaemia. She had been given prednisone 40
mgld, and was now on maintenance doses of 5 mg on alternate
days. Anabolic androgens (oxymetholone and mentenolone
acetate) at a dose of 2 mg/kg had been ineffective. Parenteral
gammaglobulin had been given on two occasions. In the past she
had received repeated transfusions with fresh whole blood and
platelets for anaemia and cutaneous bleeding. Clinical
examination was negative apart from pallor.
Initial investigations revealed a haemoglobin concentration of
4 gldl, a total granulocyte count of 0,2 x 109/1, and a platelet
count consistently lower than 20 x 10911. Bilirubin, liver enzyme,
total protein, urea, and creatinine levels were normal. The
cytomegalovirus titre was 1/64, and hepatitis B surface antigen
was not demonstrable. .
In April 1978 she underwent transplantation of bone marrow
from a compatible sibling, which was uneventful apart from a
single episode of septicaemia requiring intravenous antibiotics.
Three months after transplantation total protein and albumin
levels were normal and the alkaline phosphatase level was raised
appropriately for her age, but liver enzyme values were found to
be between 5 and 10 times normal. Radio-immunoassay for
hepatitis B surface antigen was now positive. No specific
treatment was given.
At approximately the same time a mild skin rash developed
and biopsy showed epidermal atrophy, basal vacuolar changes,
slight hyperkeratosis, and individual cell necrosis. 0 treatment
for this was given and an insignificant rash persists. Liver
enzyme values had returned to normal. Liver biopsy was
refused.
Comment. While this patient has histologically proven
cutaneous GVDH it is so mild as to require no treatment. The
normal liver biochemical findings and the absence of gastro-
intestinal tract symptoms, particularly in the face of a proven
episode of hepatitis B antigenaemia, make viral hepatitis the
most obvious diagnosis.
Case 4
This 18-year-old White girl presented with acute.
myelomonoblastic leukaemia in April 1976. Complete remission
was induced with a combination of cytosine arabinoside and
daunorubicin 6 One year later she reiapsed; remission was
reinduced with TRAMPCO(L)' but she relapsed a second time 6
months later, and bone marrow transplantation was decided
upon. The patient was then asymptomatic' and physical
examination was negative. Apart from 60% myeloblasts in the
bone marrow all laboratory investigations, including- liver
function tests, gave normal results. Cytoreduction· was
undertaken with oral busulphan (l mg/kg/24 h) and the
epipodophyllotoxin VP 16-213 (200 mg intravenously daily on
days -7, --6, -5 and -4). In addition she was conditioned with an
intravenous infusion of cyclophosphamide 60 mg/kg/24 h on
days -3 and -2, with special attention to fluid and electrolyte
balance. After 1 day's rest 1000 rad midline total-body
irradiation was given from a cobalt source. The patient was then
given hyperalimentation as well as anti-emetics; menorrhagia
was controlled with conjugated oestrogens and hydroxy-
progesterone.
The initial course was uneventful except for mild diarrhoea
which responded promptly to codeine phosphate, and
unexplained pyrexia managed with intravenous cephalothin,
gentamicin and carbenicillin. Routine post-transplantation
immunosuppression with methotrexate was given. By the 17th
day after transplantation engraftment was documented, all
support ,and antibiotic therapy was withdrawn, and the results of
biochemical, hepatic and renal re-evaluation in anticipation of
her discharge were normal.
On the 18th day tender hepatomegaly with ascites developed
suddenly and liver failure progressed rapidly, leading to the
patient's death within 3 days. Autopsy confirmed engraftment
and revealed no abnormality apart from a grossly congested liver
weighing 2480 g. There was no obstruction to any of the large
hepatic veins, and histological study revealed extensive
centrilobular congestion with necrosis of the parenchyma. A
narrow rim of haemosiderin-laden liver cells survived around
the portal tract and small numbers of lymphoid cells were
present in the sinusoids. Central veins showed minimal
separation of the endothelial lining cells from the basement
membrane by inflammatory cell infiltration, but no thrombi
were seen. The details have been reported previously.8
Comment. The fulminating hepatic necrosis caused by the
Budd-Chiari syndrome has been attributed to the cumulative
hepatotoxic effects of the many cytotoxic drugs this patient
received in the 18 months before transplantation. The additional
radiotherapy could have contributed to the microvascular
response, but this remains unproven. The possibility that the
veno-occlusive disease might have been due to GVHD was
discarded on the basis of normal skin and gastro-intestinal tract
findings.
Case 5
A 22-year-old White man with acute myeloblastic leukaemia
presented with a brief history of tiredness and malaise.
Examination was negative except for a 1 cm splenomegaly.
Initial investigation revealed a haemoglobin concentration of
12,5 gldl, a reticulocyte index of 0,3%, a white cell count of 3,5 x
10911 with 11% neutrophils, 5% eosinophils, 1% basophils, 38%
lymphocytes (some atypical), 6% monocytes, 3% promyelocytes,
5% myelocytes, 31 %metamyelocytes, and a platelet count of 146
x 10911. All biochemical values were normal.
Initial bone marrow aspiration biopsy was thought to show
features of acute myeloblastic leukaemia. Treatment began with
our standard three-drug regimen. 9 On day 10 a second bone
marrow aspirate and trephine biopsy showed residual disease,
and on review the diagnosis was changed to acute lymphoblastic
leukaemia (Ll-FAB classification).1O This may well have
accounted for the poor response to treatment. Remission was
successfully induced with L-asparaginase, vincristine,
adriamycin and prednisone. He was offered bone marrow
transplantation once complete remission had been consolidated.
He was conditioned with cyclophosphamide and 1000 rad
total-body irradiation before the procedure. From the 5th day
after transplantation he had a persistent mild diarrhoea, and on
day 14 he developed a skin rash with histological features
compatible with GVHD; treatment with prednisone was begun.
A herpetic rash and mouth ulcers were treated with 5-
deoxyuridine with some improvement. On day 24 he developed
pyrexia associated with jaundice and abdominal tenderness with
a palpable gallbladder but no hepatomegaly. Ultrasonography
confirmed dilation of the gallbladder and proximal bile ducts.
The total bilirubin level rose to 384 ,umol/l, the conjugated
bilirubin level was 327 ,umol/l, the alkaline phosphatase level 264
lUll, and the SGOT level 204 lUll. His condition deteriorated
rapidly, and JUSt before his death Salmonella species were
isolated from blood cultures.
At autopsy the gallbladder was found to be markedly
distended, with dilation of the cystic and common bile ducts
indicating recent obstruction. The whole of the mucosa of the
common bile duct and cystic duct had 9'loughed and had
impacted firmly, causing obstruction. No gallstones were
observed.
On histological examination the bile duct was found to be
entirely necrotic with extravasation of bile into the subjacent
connective tissue, where fat necrosis had occurred. There was no
e\'idence of inflammation and no fibrosis. The liver was
markedly enlarged and histological examination showed a large
number of bile infarcts, mainly situated around the central veins.
The presence of bile plugs in the canaliculi were compatible with
the obstruction. There was some periportal chronic
inflammatory cell infiltration and hepatocytes were widely
separated, some being nucleate. The skin showed widespread
involvement with atrophy of the epidermis and papillary dermis
with hyperkeratosis. There was' a thick reticular dermis with foci
of collagen necrosis with infiltrating histiocytes. The whole of
the gastro-intestinal tract was extensively ulcerated.
Comment. The jaundice in this patient was obstructive and
resulted from sloughing and impaction of the mucosa of the
common bile and cystic ducts. The cause remains unknown, but
it is our opinion that this reflects a change similar to that seen in
the gastro-intestinal tract after mucosal destruction due to the
cumulative effects of cytotoxic agents and superimposed
radiotherapy. The acute.GVHD in the period immediately after
transplantation had responded dramatically to prednisone, and
while the high-dose steroids may have effected the changes in the
liver and the skin the findings in these two systems at autopsy
were difficult to reconcile with this diagnosis. The changes in the
gastro-intestimil tract were impossible to resolve, and would be
entirely compatible with drug- and radiation-induced ulceration
which appeared histologically to be in the process of recovery.
Case 6
A l2-year-old Cotoured boy with proven severe acute aplastic
anaemia was referred for elective bone marrow transplantation.
Physical signs were limited to mild pallor. Peripheral blood and
bone marrow samples showed features diagnostic ofsevere acute
aplastic anaemia, but the biochemical profile was normal and
tests for viral infection were all negative.
The patient underwent uneventful transplantation of bone
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marrow from an HLA-identical and MLC-non-reactive sibling,
with engraftment established by day 12. Since the present
protocol is examining the role of cyclosporin A1I in the control of
GVHD he was given this agent in a dose of 15 mg/kg body
weight, and plasma levels were monitored regularly.
In the 3rd week after transplantation the patient became
jaundiced, with rapid elevation of liver enzyme levels, conjugated
hyperbilirubinaemia, and a rising alkaline phosphatase level.
Cramping abdominal pains were present and examination
showed the right upper quadrant to be tender. Ultrasonography
revealed a large cystic mass occupying the anatomical situation of
the gallbladder. An emergency surgical operation confirmed the
presence of a sterile mucocele, which was drained. Otherwise the
laparotomy revealed nothing abnormal. Bile could be milked
through the common bile duct only with the greatest difficulty
but no stones were demonstrated, and it was elected not to
explore the common bile duct.
The patient tolerated the surgical procedure well; within 3
days bowel motility had returned and both skin rash and
diarrhoea now became evident.
A liver biopsy specimen taken at operation showed only
centrilobular liver cell necrosis ofa focal nature,;md there was no
evidence of GVHD in the liver or in a skin biopsy.
The patient remained well clinically but the jaundice
increased rapidly. In view of the known hepatotoxicity of
cyclosporin A the dose was further reduced, and at the end ofthe
3rd postoperative week the drug was discontinued because the
jaundice was deepening, and this drug was replaced by a
corticosteroid (prednisone 1 mg/kg/24 h). The response was
dramatic, and within 48 hours there was clinical and biochemical
evidence of resolution of the hepatitis.
On the 28th day after transplantation the patient developed
melaena and had a 2-litre haematemesis. Although liver enzyme
and alkaline phosphatase levels were now normal, suggesting
that cell necrosis and obstruction had been reversed, the
prothrombin time was only 25% of normal. Further haemostatic
evaluation showed the laboratory characteristics of severe
hepatocellular dysfunction; treatment with fresh whole blood,
cryoprecipitate, factor concentrates and platelet infusions
returned the prothrombin time to normal. Bleeding from the
gastro-intestinal tract senled within 6 hours.
During emergency resuscitation the patient had aspirated
blood, and right lower lobe pneumopia was confirmed
radiologically. Although only transiently hypotensive oliguria
developed, the patient died of refractory cardiorespiratory
failure later the same night.
Autopsy confirmed engraftment and consolidation of the right
lower lobe. The major anatomical changes were confined to the
abdomen. The liver was enlarged and bile-stained, the common
bile duct was patent and the gallbladder healthy. There was
extensive mucosal desquamation of the entire gastro-intestinal
tract, this being maximal in the left colon and the rectum.
Histological examination showed necrOtizing enterocolitis but
no evidence of GVHD. The causation of this lesion, which
contributed to his septicaemia, is unexplain.ed. 'one ofthe other
organs, notably liver and skin, showed any evidence of GVHD.
Comment. In this patient the postoperative jaundice could
have occurred for any of three reasons. Firstly, there might have
been transient obstruction to the common bjle duct with mucosal
oedema, as in the previous case. \1(lhether the corticosteroids
were instrumental in reducing the oedema and restoru,g p",:encv
to hepatic drainage is unknown. Secondly, the ;::.tiept may have
had GVHD with the maximum effects in the gastro-intestinal
tract and the liver, skin changes being masked by the
administration of cyclosporin A.12 Alternatively, the jaundice
might have been related to cyclosporin ad!Jlinistration and its
rapid reversal to withdrawal of the drug and commencement ofa
corticosteroid. During the pancytopenic period the patient was
pyrexial and presumably septicaemic, although blood cultures
were negative. It therefore remains a fourth possibility that the
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liver disease may have been related to infection, in part at least.
In support of this is the finding of gas in the pelvic
retroperitoneum, but postmortem bacteriological investigation
was not undertaken.
Discussion
Jaundice is common after bone marrow transplantation. The
causes vary widely and successful management depends upon
accurate di!lgnosis. However, these patients are often exposed to
more than one well-recognized cause of jaundice both before and
after transplantation.
GVHD is a clinical syndrome resulting from an acute
inflammatory process mediated by donor lymphocytes and
directed against antigens in the target organs of the host. 13 pto
70% of patients may be affected, and t\vo clinical variants have
been recognized. The first is an acute or fulminating illness
characterized by extensive skin involvement, voluminous
diarrhoea and hepatiti. In chronic GVHD cutaneous
involvement predominates and sclerodermatous features may
develop, liver and gastro-intestinal tract involvement being less
obvious. Both clinical and histopathological staging is possible.l-l
GVHD is a major barrier to the more widespread use of bone
marrow transplantation, and while the incidence and severity
may be decreased by histocompatibility matching and poSt-
transplantation immunosuppression, both adequate prophylaxis
and therapy are lacking. I;
The hepatic component is characterized by hepatomegaly and
jaundice. Elevated total and conjugated bilirubin, alkaline
phosphatase and transaminase levels are characteristic
biochemical features. Progression to liver fa,ilure may occur.
The histological diagnosis may be difficult bur is aided when
there is proven cutaneous involvement, since the latter
characteristically precedes the hepatitis. Histologically there is
degeneration and eosinophilic necrosi of the hepatic
parenchymal cells, resulting in irreguJarity of the limiting plates
and foci of hepatocellular necrosis of varying size within the liver
lobule. Lymphocytes infiltrate the portal areas and may be
observed adjacent to the necrotic hepatocytes, where
macrophages will sometimes also aggregate. Kupffer cell
hyperplasia and haemosiderosis occur, while the parenchymal
cells show variable farty change and may also accumulate iron.
The most constant finding is that ofdegeneration and necrosis of
the epithelium of bile ducts. Intrahepatic bile stasis is variable
and often minimal. The epithelial lesion is most reliable in
distinguishing hepatic GVHD from other types of hepatitis and
is the basis for histological rating. 14 In a double-blind study in
the dog the specificity of changes in the small bile ducts was
confirmed, although it has been suggested that a viral infection
may produce similar features. 16
GVHD may also affect the small centrilobular and sublobular
hepatic veins, giving rise to a Budd-Chiari syndrome with
hepatic failure. 17 Histologically there is non-thrombotic
obliteration of these small vessels by subintimal oedema and
cellular infiltration with early fibrosis. The changes are most
prominent ill he small lobular veins, the lumens of which appear
compromised to varying degrees by a collar of the oedematous
tissue or reticulin. The incrimination of GVHD in this syndrome
is complicated by the occurrence of an essentially similar picture
in patients receiving intensive radiation or chemotherapy,S
although there does not appear to be any correlation with the
type of immunosuppressive regimen employed. This lesion is
distinguishable from the classic Budd-Chiari syndrome by lack
of involvement of the large hepatic veins and intrahepatic
radicals of the inferior vena cava, and the absence of thrombi.
Viral hepatitis may be difficult to distinguish from GVHD
and is a potential complication in transplant patients because of
the multiple transfusions to which they are exposed. The
fmdings of hepatitis B surface antigenaemia in one of our
patients raises the possibility that in some of the other cases
histological changes might have been due to non-A, non-B
hepatitis or cytomegalovirus or hepatitis A infection. The points
of contrast are destruction of the small bile ducts in
cholangiolytic viral hepatitis, where this change may be severe,
and ballooning degeneration of hepatic cells. In contrast, in
GVHD there is eosinophilic necrosis of single cells or loss of
small groups of hepatocytes, and prominent involvement of the·
bile ducts.
Differentiation from cytomegalovirus infection is often more
difficult.
Extensive involvement of the liver and gastro-intestinal tract
with cytomegalovirus is a common complication of GVHp, and
the characteristic inclusion bodies in biopsy specimens frolJl the
liver and gastro-intestinal tract and a rising titre of
cytomegalovirus antibodies confirm the presence of: two
processes without clearly delineating the contribution of each to
changes in the liver.
Bach of the 6 patients also had a clinical course compatible
with drug administrations. Methotrexate produces dose-
dependent hepatotoxicity. The histological features include
parenchymal fany change and necrosis, Kupffer cell
proliferation, and portal tract infiltration. Hepatic fibrosis and
cirrhosis occur with longer term therapy. IS Furthermore, the
hepatotoxicity caused by methotrexate increases when this drug
is administered with other cytotoxic agems. 19
In addition, amphotericin B may cause hepatocellular
dysfunction and jaundice and occasionally acute liver failure. 20.21
The aminoglycosides are associated with mild increases in
hepatic transaminase, alkaline phosphatase and bilirubin
levels,22 while the cephalosporins23 may also alter liver enzyme
and alkaline phosphatase levels.
More recently cyclosporin A has been used to suppress
immune competence, primarily in an attempt to control
GVHD.II This drug is known to be hepatotoxic, and in our last
patient, histological examination of the liver demonstrated
changes compatible with either viral or drug-induced
centrilobular hepatic cell necrosis. The absence of any
serological evidence of viral infection and the dramatic response
to withdrawal of cyclosporin A and substitution of
corticosteroids is interpreted as a reversal of drug-induced
hepatitis. The lesson to be learned from this experience is that
careful monitoring of plasma levels with radio-immunoassay and
dosage adjustment may avert even transient episodes of this
nature.
Septicaemia is known to cause jaundice,24 and blood cultures
need not be positive. Biochemical investigations reveal
conjugated hyperbilirubinaemia with only a modest rise in
serum alkaline phosphatase and transaminase levels.
Histological examination of the liver shows mild-to-moderate
bile stasis and nonspecific changes such as fatty infiltration and
the presence of inflammatory cells in the portal tract. The
difficulty is that many of the patients are pyrexial, organisms fail
to grow from blood or other cultures, and more than one cause
for jaundice is already present. The cont ribution of infection in
the individual patient may therefore be difficult to define
precisely.
Of great interest has been our experience with three recent
patients in whom mechanical obstruction to biliary drainage
resulted in jaundice following bone marrow transplantation. In
one patient, not included in this report, jaundice, conjugated
hyperbilirubinaemia and an acute abdomen necessitated
emergency exploration in another hospital. Laparotomy was
entirely negative apart from the presence of pigment stones in
the gallbladder and one stone firmly impacted in the common
bile duct. The postoperative course was uneventful and despite
intensive studies an explanation for biliary stone formation has
not been established. Two patients in this series presented with
jaundice immediately after the transplant. We do not think that
obstruction of the common bile duct by a mucosal cast (case 5)
has ever been reported before. The reason for the desquamation
is not known, but. it may reflect the same changes seen in the
gastro-intestinal tract and is probably attributable to the high-
dose cyclophosphamide and radiotherapy used to condition the
patient. \XThether the pre\'ious fulminating GVHD made any
contribution must remain speculative, particularly since
histological examination of the liver, skin and gastro-intestinal
tract provided no evidence for that diagnosis at autopsy.
Furthermore, examination of the desquamated mucosa showed
only cell necrosis and oedema. The reluctance of the surgeons to
undertake emergency urgery is understandable, but this should
nor have presented an insurmountable problem. In retrospect,
exploratory laparotomy, confirmation of the lesion a'nd an
appropriate drainage operation might well have prevented the
death of this patient.
This experience undoubtedly influenced management when a
similar problem was encountered in our last patient. Although
the operati\'e risk was as great, he tolerated the surgical
exploration well and drainage by cholecystostomy was effective.
It is noteworthy that considerable difficulty was experienced in
milking bile through the common duct. Notwithstanding the
grave clinical condition of these patients, we have come to realize
that this entity may be a previously unrecognized complication
in the early transplant period; it would appear best managed by
exploration of the common bile duct and T -tube drainage. In
this patient the causation of the lesion is again uncertain,
although there is no histological evidence of GVHD. The fact
that the same changes (namely oedema and mucosal
desquamation) were present throughout the gastro-intestinal
tract, may explain the common bile duct lesion adequately.
Because jaundice after bone marrow transplantation is
frequently multifactorial it poses major diagnostic difficulties. A
differential diagnosis will often include acute or chronic GVHD,
viral hepatitis, drug-associated liver disease and septicaemia.
Less frequently the Budd-Chiari syndrome or mechanical
obstruction of the common bile duct may be encountered.
Rational therapy is only possible after accurate diagnosis and, as
in the case of mechanical biliary obstruction, early diagnosis and
surgical intervention are necessary. The increasing use of
cytotoxic drugs, including new immunosuppressive agents such
as cyclosporin A, emphasizes the need to be aware of these
complications and the role ofearly liver biopsy in the histological
diagnosis of GVHD.
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